Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
06/21/2012 | WO2012082800A2 System and method for cell-type specific comparative analyses of different genotypes to identify resistance genes |
06/21/2012 | WO2012082753A2 Polymerization of nucleic acids using activation by polyphosphorolysis (app) reactions |
06/21/2012 | WO2012082573A1 Predictive methods and methods of treating arthritis using il-17 antagonists |
06/21/2012 | WO2012082331A1 Methods for screening antibiotic compounds |
06/21/2012 | WO2012082074A1 Method of detecting resistance to cancer therapy |
06/21/2012 | WO2012081928A2 Method for detecting methylation of the bowel-cancer-specific methylation marker gpm6a gene in order to diagnose bowel cancer |
06/21/2012 | WO2012081908A2 Rna aptamer for teiocoic acid in staphylococcus aureus |
06/21/2012 | WO2012081907A2 Rna aptamer for e. coli o157:h7 strain |
06/21/2012 | WO2012081906A2 Rna aptamer for binding to ompc protein in salmonella tiphimirium strain |
06/21/2012 | WO2012081898A2 Marker for predicting stomach cancer prognosis and method for predicting stomach cancer prognosis |
06/21/2012 | WO2012081856A2 Method for preparing nucleic acid probe-coated porous solid support strip |
06/21/2012 | WO2012081539A1 Method for analysis for component to be assayed |
06/21/2012 | WO2012081502A1 SCREENING METHOD INDEXED USING EphA4 CLEAVAGE REACTION BY GELATINASE |
06/21/2012 | WO2012081470A1 Method for forming cell aggregate |
06/21/2012 | WO2012081200A1 Object size examination method |
06/21/2012 | WO2012080976A1 Lar protein-specific ligand |
06/21/2012 | WO2012080816A2 Single nucleotide polymorphism associated with risk of insulin resistance development |
06/21/2012 | WO2012080754A2 Oligonucleotide probe set and methods of microbiota profiling |
06/21/2012 | WO2012080753A1 Diagnosis of crohn's disease |
06/21/2012 | WO2012080721A2 Plasma cell disorders |
06/21/2012 | WO2012080541A1 Novel reverse transcriptases of human immunodeficiency virus type 2 group o |
06/21/2012 | WO2012080503A1 The abcg1 gene as a marker and a target gene for treating obesity |
06/21/2012 | WO2012080359A2 Mhc genes and risk of graft versus host disease |
06/21/2012 | WO2012079578A1 Selective killing of cancer cells |
06/21/2012 | WO2012079490A1 Method for constructing dna sequencing library and use thereof |
06/21/2012 | WO2012079486A1 Method of preparing dna sample for sequencing and use thereof |
06/21/2012 | WO2012058689A8 Methods, kits and arrays for screening for, predicting and identifying donors for hematopoietic cell transplantation, and predicting risk of hematopoietic cell transplant (hct) to induce graft vs. host disease (gvhd) |
06/21/2012 | WO2012056236A3 Analytical methods and arrays for use in the identification of agents inducing sensitization in human skin |
06/21/2012 | WO2012051622A3 Microvesicle-based assays |
06/21/2012 | WO2012051415A3 Inhibitors of acid ceramidase and the uses thereof in treating disorders including cancer |
06/21/2012 | WO2012051165A3 Mir-211 expression and related pathways in human melanoma |
06/21/2012 | WO2012050627A3 Dopaminergic neurons derived from induced pluripotent stem cells and method of making same |
06/21/2012 | WO2012049225A3 Marker sequences for systemic lupus erythematosus and the use thereof |
06/21/2012 | WO2012048340A3 High-throughput immune sequencing |
06/21/2012 | WO2012047865A3 Electrically conductive polymer nanowires with incorporated viruses |
06/21/2012 | WO2012047584A3 Macaca fascicularis ccl17 |
06/21/2012 | WO2012047015A3 Multiplex microfluidic device for selecting nucleic acid aptamers, and high throughput selection method for nucleic acid aptamers using same |
06/21/2012 | WO2012045905A3 Method for the diagnosis, prognosis and treatment of breast cancer metastasis |
06/21/2012 | WO2012038839A3 Increasing confidence of allele calls with molecular counting |
06/21/2012 | WO2012034094A3 Integrated microfluidic radioassay and imaging platform for small sample analysis |
06/21/2012 | WO2012026979A3 Marker of diagnosis and prognosis in multiple sclerosis |
06/21/2012 | WO2012019187A3 Ligation-based detection of genetic variants |
06/21/2012 | WO2012012055A3 Method for monitoring a sterilization process |
06/21/2012 | WO2011154008A9 Microrna classification of thyroid follicular neoplasia |
06/21/2012 | US20120159676 Protein having glycoalkaloid biosynthetic enzyme activity and gene encoding the same |
06/21/2012 | US20120159675 Fertility restoration for ogura cytoplasmic male sterile brassica and method |
06/21/2012 | US20120159672 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
06/21/2012 | US20120159661 T-Bet Compositions and Methods of Use Thereof |
06/21/2012 | US20120159660 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids |
06/21/2012 | US20120159658 Extracellular vesicles derived from gram-positive bacteria, and use thereof |
06/21/2012 | US20120159655 Methods using axl as a biomarker of epithelial-to-mesenchymal transition |
06/21/2012 | US20120157542 Method to assess prognosis and to predict therapeutic success in cancer by determining hormone receptor expression levels |
06/21/2012 | US20120157522 B. Anthracis Prevention and Treatment: Mutant B. Anthracis Lacking Luxs Activity and Furanone Inhibition of Growth, AI-2 Quorum Sensing, and Toxin Production |
06/21/2012 | US20120157514 Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
06/21/2012 | US20120157507 USP47 Inhibtors and Methods to Induce Apoptosis |
06/21/2012 | US20120157474 Methods of Identifying and Using General or Alternative Splicing Inhibitors |
06/21/2012 | US20120157385 Cyclosporin conjugates |
06/21/2012 | US20120157381 Compositions and methods for cardiac tissue repair |
06/21/2012 | US20120157379 Gastric Inhibitory Peptide Variants and Their Uses |
06/21/2012 | US20120157378 Methods and Compositions for Predicting a Subject's Susceptibility To and Risk of Developing Type 2 Diabetes |
06/21/2012 | US20120157375 Identification of Inhibitors of a Bacterial Stress Response |
06/21/2012 | US20120157371 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds |
06/21/2012 | US20120157347 Method for hla typing |
06/21/2012 | US20120157346 Programmable illumination pattern for transporting microparticles |
06/21/2012 | US20120157345 Methods and Compositions for Obtaining and Using Biologically Active Multi-Protein Complexes |
06/21/2012 | US20120157344 Gene expression signature for classification of kidney tumors |
06/21/2012 | US20120157343 System and Methods to Quantify and Amplify Both Signaling and Probes for cDNA Chips and Gene Expression Microarrays |
06/21/2012 | US20120157342 Predictive biomarkers useful for cancer therapy mediated by a wee1 inhibitor |
06/21/2012 | US20120157340 Pathways characterization of cells |
06/21/2012 | US20120157339 Molecular Markers and Assay Methods for Characterizing Cells |
06/21/2012 | US20120157338 Method for determining the risk of developing brain metastasis, and a kit to carry out said method |
06/21/2012 | US20120157336 miRNA FINGERPRINT IN THE DIAGNOSIS OF DISEASES |
06/21/2012 | US20120157334 Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms |
06/21/2012 | US20120157333 Oligonucleotides useful for detecting and analyzing nucleic acids of interest |
06/21/2012 | US20120157331 Methods of detecting susceptibility to leukemia/ lymphoma and induction of leukemia and lymphomas |
06/21/2012 | US20120157329 Method and Device for the in Vitro Analysis for MRNA of Genes Involved in Haematological Neoplasias |
06/21/2012 | US20120157327 Labelling Strategies for the Sensitive Detection of Analytes |
06/21/2012 | US20120157326 Stem accelerated isothermal nucleic acid amplification technology |
06/21/2012 | US20120157324 Methylation biomarkers and methods of use |
06/21/2012 | US20120157323 Two-hybrid based screen to identify disruptive residues at multiple protein interfaces |
06/21/2012 | US20120156763 Apparatus and Methods for Using Biological Material to Discriminate an Agent |
06/21/2012 | US20120156716 Methods For The Isolation, Accumulation, Characterization And/Or Identification Of Microorganisms Using A Filtration And Sample Transfer Device |
06/21/2012 | US20120156715 Environmental Sentinel Biomonitor System (ESB) |
06/21/2012 | US20120156713 Method for analyzing and/or treating a fertilized egg, and corresponding system |
06/21/2012 | US20120156712 System and method for identification of biological tissues |
06/21/2012 | US20120156708 Method For Simultaneously Determining Multiple Coagulation Proteases |
06/21/2012 | US20120156706 process for the identification and preparation of a (r)-specific omega-transaminase |
06/21/2012 | US20120156705 luciferases and uses thereof |
06/21/2012 | US20120156697 Method for Identifying an Agent that Inhibits Candida albicans-Mediated Host Cell Differentiation |
06/21/2012 | US20120156696 container for forming a cell aggregate and a method for forming a cell aggregate |
06/21/2012 | US20120156690 Method for diagnosing hemangiosarcoma in canine using detection of thymidine kinase activity |
06/21/2012 | US20120156686 Multifunctional particles providing cellular uptake and magnetic motor effect |
06/21/2012 | US20120156684 Selection method of induced pluripotent stem cells |
06/21/2012 | US20120156683 One-step method of elution of dna from blood samples |
06/21/2012 | US20120156682 Allelic discrimination analysis using an efficiency related value (efr) |
06/21/2012 | US20120156681 Composition for diagnosis of liver metastasis of colorectal cancer and the use thereof |
06/21/2012 | US20120156680 Synthesis of four-color 3'-o-allyl modified photocleavable fluorescent nucleotides and related methods |
06/21/2012 | US20120156679 Methods for making transcription products |
06/21/2012 | US20120156678 Binding-induced hairpin detection system |
06/21/2012 | US20120156677 Detection and Quantification of Hydroxymethylated Nucleotides in a Polynucleotide Preparation |